Literature DB >> 320768

Fluoro-immuno-cytoadherence (FICA): A new method for the identification and enumeration of antigen-binding cells.

E Richter, G Wick.   

Abstract

Antigen-coated particles of cross-linked dextran may be used for affinity chromatography of antibodies and for the fractionation of lymphoid cells with appropriate surface receptors. Furthermore, such particles serve as convenient substrates for quantitative immunofluorescence tests. The fluoro-immuno-cyto-adherence (FICA) is a simple technique which combines affinity chromatography and immunofluorescence, provides durable antigen-coated substrates and allows the identification, enumeration and characterization of lymphoid cells capable of binding an antigen, covalently linked via a spacer onto the surface of dextran beads. In the present study chicken thyroglobulin (TG) or bovine serum albumin (BSA) were coupled onto fluorescein and rhodamin-labelled or unlabelled Sephadex G-25 beads by means of spacer molecules. The specificity and degree of antigen-coating were controlled by indirect immunoflourescence. For the study of antigen-binding cells the different antigen-coated beads were mixed with suspensions of peripheral blood lymphoid cells from Obese strain (OS) chickens with spontaneous hereditary autoimmune thyroiditis, or with cells from BSA-immunized or unimmunized normal White Leghron chickens. Specific adherence of OS lymphocytes to TG-coated beads and of lymphocytes from BSA-immunized chickens to BSA-beads was found. The test and control preparations are observed simultaneously under the fluorescence microscope where the distinction of beads coated with different antigens can be made on the basis of the color of their fluorescence. Results obtained with the FICA technique are in good agreement with those of conventional rosette tests.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 320768

Source DB:  PubMed          Journal:  Z Immunitatsforsch Immunobiol        ISSN: 0340-904X


  3 in total

1.  Improved immunogenicity of Newcastle disease virus inactivated vaccine following DNA vaccination using Newcastle disease virus hemagglutinin-neuraminidase and fusion protein genes.

Authors:  Masoumeh Firouzamandi; Hassan Moeini; Davood Hosseini; Mohd Hair Bejo; Abdul Rahman Omar; Parvaneh Mehrbod; Aini Ideris
Journal:  J Vet Sci       Date:  2016-03-22       Impact factor: 1.672

2.  Improving the potency of DNA vaccine against chicken anemia virus (CAV) by fusing VP1 protein of CAV to Marek's Disease Virus (MDV) type-1 VP22 protein.

Authors:  Hassan Moeini; Abdul Rahman Omar; Raha Abdul Rahim; Khatijah Yusoff
Journal:  Virol J       Date:  2011-03-14       Impact factor: 4.099

3.  Newcastle Disease Virus Hemagglutinin Neuraminidase as a Potential Cancer Targeting Agent.

Authors:  Ali Baradaran; Khatijah Yusoff; Norazizah Shafee; Raha Abdul Rahim
Journal:  J Cancer       Date:  2016-01-29       Impact factor: 4.207

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.